Zevia PBC ( ZVIA ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Amy Taylor - CEO, President & Director Girish Satya - EVP, CFO & Principal Accounting Officer Conference Call Participants Anne Mcguinness James Salera - Stephens Inc., Research Division Sarang Vora - Telsey Advisory Group LLC Andrew Strelzik - BMO Capital Markets Equity Research Eric Serotta - Morgan Stanley, Research Division Presentation Operator Greetings, and welcome to the Zevia PBC Q3 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Zevia (ZVIA) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.04 per share a year ago.
Zevia PBC targets the zero-sugar beverage trend with naturally sweetened sodas, teas, and energy drinks, appealing to health-conscious consumers. Zevia's financials show improving gross margins, stabilizing sales, and narrowing losses, supported by a debt-free balance sheet and expanding distribution. Valuation is attractive, significantly lower than peers like Celsius and Vita Coco, reflecting both risk and potential upside.
Zevia PBC (NYSE:ZVIA ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Amy E. Taylor - CEO, President & Director Girish Satya - EVP, CFO & Principal Accounting Officer Conference Call Participants Daniel Alan Goldman - Unidentified Company BMO Capital Markets Corp. - Unidentified Company Ethan David Huntley - Goldman Sachs Group, Inc., Research Division James Ronald Salera - Stephens Inc., Research Division Sarang Vora - Telsey Advisory Group LLC Jean Fontana - Unidentified Company Operator Good day, everyone, and welcome to today's Zevia's Second Quarter 2025 Earnings Call.
Zevia (ZVIA) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.09 per share a year ago.
Does Zevia (ZVIA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zevia PBC (NYSE:ZVIA ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Jean Fontana - Senior MD, ADDO Investor Relations Amy Taylor - President & CEO Girish Satya - CFO & Principal Accounting Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Jim Salera - Stephens Eric Serotta - Morgan Stanley Andrew Strelzik - BMO Sarang Vora - Telsey Advisory Group Eric Des Lauriers - Craig-Hallum Operator Greetings, and welcome to the Zevia PBC First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode.
Zevia (ZVIA) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.10 per share a year ago.
Zevia PBC had a weak 2024 with distribution losses and product line discontinuations, but the company is looking to regain growth momentum with increased Walmart distribution in 2025. Zevia still needs a much larger scale as competitors have a massive cost advantage from scale efficiencies in marketing, distribution, and other operating expenses. Zevia still generates losses. ZVIA stock currently prices in moderate further distribution gains and significant efficiencies in expenses, making ZVIA's risk-to-reward neutral for now.
Zevia PBC (NYSE:ZVIA ) Q4 2024 Earnings Conference Call February 26, 2025 8:30 AM ET Company Participants Alex Liskin - ICR Amy Taylor - President and CEO Girish Satya - Principal Accounting Officer and CFO Conference Call Participants James Salera - Stephens Inc. Daniel Gold - BMO Sarang Vora - Telsey Advisory Group Operator Ladies and gentlemen, greetings and welcome to the Zevia PBC Q4 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Zevia (ZVIA) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.14 per share a year ago.
Zevia (ZVIA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.